The Law of Chemical, Metallurgical and Pharmaceutical PatentsHoward I. Forman Central Book Company, 1967 - 863 lappuses |
No grāmatas satura
1.–3. rezultāts no 36.
338. lappuse
... motion to shift the burden of proof , then it will be disposed of as part of the subject matter relating to the motion to shift at the time that the matter is decided by the Primary Examiner . If there is no motion to shift , and no motion ...
... motion to shift the burden of proof , then it will be disposed of as part of the subject matter relating to the motion to shift at the time that the matter is decided by the Primary Examiner . If there is no motion to shift , and no motion ...
492. lappuse
... motion to dissolve for unpatentability . Similarly , every interfer- ant should study his opponent's application most carefully to as- certain whether it in fact supports the counts , and move to dissolve if they cannot properly be read ...
... motion to dissolve for unpatentability . Similarly , every interfer- ant should study his opponent's application most carefully to as- certain whether it in fact supports the counts , and move to dissolve if they cannot properly be read ...
519. lappuse
... motions . MOTIONS New Rule 224 requires that a party seeking the benefit of the filing date of a prior application , either foreign or domestic , which is not included in the notice of interference must file a motion to that effect ...
... motions . MOTIONS New Rule 224 requires that a party seeking the benefit of the filing date of a prior application , either foreign or domestic , which is not included in the notice of interference must file a motion to that effect ...
Saturs
Chapter | 1 |
By CHARLES C PRICE | 15 |
By JOHN T CONNOR AND I LOUIS WOLK | 25 |
Autortiesības | |
15 citas sadaļas nav parādītas.
Bieži izmantoti vārdi un frāzes
2nd Cir affidavit alloy assignment basis Board of Appeals chemical compound chemical patent chromium claims Company considered Corp court held Court of Customs Customs and Patent decision diligence disclosed discovery discussed doctrine of equivalents double patenting drug effect estoppel Examiner example fact filing date granted industry infringement ingredients interference interference proceedings invalid inventor inventorship involved issue license licensor limited machine manufacture Markush material ment method motion obtain obvious party Patent Act Patent Appeals patent application Patent Attorney Patent Examining patent law Patent Office patent system patented invention pharmaceutical present printed publication prior art priority problem proof properties question reason reduction to practice reference reissue rejection result royalty Rule Section 103 situation skilled SOC'Y specification statement statute statutory steel subject matter supra thing tion U.S. Patent United unobvious vention